Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04727567 · ClinicalTrials.gov registry record
Evaluation of a Personalized Care Management Program for High Hospital Utilizers
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 454
- Enrollment target
NCT04727567: Completed study, sponsored by Wake Forest University Health Sciences.
NCT04727567 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 454 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04727567 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 454 participants
- Enrollment target
Study Summary
This randomized clinical trial intends to evaluate the effectiveness of enrollment in Atrium Health's Multiple Visit Patient (MVP) care management program compared to usual care on reducing 12-month total inpatient hospital utilization among patients with high past volume of hospital inpatient stays.
Primary Outcome
Inpatient encounter is defined as an admission to an Atrium Health acute care hospital
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 454 participants |
| Start Date | 2020-04-23 |
| Est. Completion | 2021-08-31 |
What the finished NCT04727567 record still lists
NCT04727567 is an observational study that tracks outcomes without assigning an intervention. The registered 454 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04727567 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04727567 about?
NCT04727567 is a clinical study titled "Evaluation of a Personalized Care Management Program for High Hospital Utilizers". This randomized clinical trial intends to evaluate the effectiveness of enrollment in Atrium Health's Multiple Visit Patient (MVP) care management program compared to usual care on reducing 12-month total inpatient hospital utilization among patients with high past volume of hospital inpatient stays...
What is the current status of trial NCT04727567?
This trial is currently completed. The enrollment target is 454 participants. The study started on 2020-04-23. Estimated completion is 2021-08-31.
Who is sponsoring clinical trial NCT04727567?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05489211 · 454 participants · Phase 2
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- NCT05655936 · 454 participants · NA
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
- NCT06510374 · 454 participants · Phase 3
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
- NCT06935357 · 454 participants · Phase 3
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI